Cognitive Behavioral Therapy for Serious Mental Illness-related Chronic Pain
(CPSMI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Chronic pain has a highly negative impact on Veterans, especially those with serious mental illness (SMI). Chronic pain leads to poorer mental health and physical functioning, and represents a critical obstacle to rehabilitation and recovery. Despite known high prevalence rates of chronic pain in SMI populations, there is little research to: a) evaluate nonpharmacological pain management strategies in this population, and b) examine directional relations between chronic pain and SMI symptoms. This study aims to address research and clinical gaps by: a) testing the feasibility and acceptability of Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) - a VA evidence-based psychotherapy for chronic pain - in Veterans with SMI, and b) better assessing the complex relation between chronic pain and psychiatric symptoms and their impact on functioning. Results from this study will inform us as to whether CBT-CP is feasible to implement, acceptable to Veterans with SMI, and worth examining in its standard or in an optimized form in a larger clinical trial.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, it focuses on nonpharmacological pain management, so it's likely you can continue your medications unless otherwise advised by your healthcare provider.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your healthcare provider.
What safety data exists for Cognitive Behavioral Therapy for Chronic Pain?
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) is considered a safe and effective treatment for chronic pain. It is an alternative to opioid analgesics and has been shown to be effective in various settings, including primary care. The therapy is well-supported by evidence, although it is underused due to accessibility issues. No specific safety concerns are highlighted in the available research, indicating it is generally safe for use.12345
Is Cognitive Behavioral Therapy for Chronic Pain safe for humans?
Is Cognitive Behavioral Therapy for Chronic Pain a promising treatment?
Yes, Cognitive Behavioral Therapy for Chronic Pain is a promising treatment. It is effective in improving pain and related issues, and it can be adapted for different groups, including children and older adults. It is also being made more accessible through online and phone options, which is important for people in areas with limited healthcare services.12367
How is Cognitive Behavioral Therapy for Chronic Pain different from other treatments for chronic pain?
Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) is unique because it focuses on changing the way people think about and respond to pain, which can help improve mood and reduce pain interference. It is also accessible through remote formats like telehealth, making it more available to people in rural or underserved areas.12678
What data supports the idea that Cognitive Behavioral Therapy for Serious Mental Illness-related Chronic Pain is an effective treatment?
The available research shows that Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) is effective in managing chronic pain. One study highlights that CBT-CP is a successful treatment for chronic pain and is especially important for people in rural areas who have less access to healthcare. Another study mentions that CBT has been a key treatment for chronic pain for many years, helping improve pain and related issues. Additionally, CBT has been adapted for different groups, like children and older adults, and can be delivered in various ways, such as online or over the phone, making it more accessible. Overall, these studies suggest that CBT-CP is a valuable treatment option for chronic pain.12378
What data supports the effectiveness of the treatment Cognitive Behavioral Therapy for Chronic Pain (CBT-CP)?
Research shows that Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) is effective in improving pain and related issues across various chronic pain conditions. It has been successfully adapted for different populations, including children and older adults, and can be delivered in various formats like online or by phone, making it more accessible.12378
Who Is on the Research Team?
Letitia Travaglini, PhD
Principal Investigator
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Are You a Good Fit for This Trial?
This trial is for Veterans with serious mental illnesses like schizophrenia or bipolar disorder who also suffer from chronic pain. Participants must be adults enrolled in VA Maryland Health Care System outpatient programs, able to give informed consent, and have a certain level of pain severity. Those with severe substance use issues or current acute pain conditions that would hinder participation are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) over 12 sessions, including an initial assessment, 10 content-specific sessions, and a booster session
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments including WHYMPI, WHODAS 2.0, VR-36, and WHOQOL-BREF
Data Collection and Evaluation
Feasibility of collecting EMA data and process evaluation to optimize CBT-CP for future trials
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Behavioral Therapy for Chronic Pain
Cognitive Behavioral Therapy for Chronic Pain is already approved in United States for the following indications:
- Chronic pain management in veterans with serious mental illness
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
VA Maryland Health Care System
Collaborator